When does Xgeva’s patent end (and what does “fin patente” mean in practice)?
“Fin patente” usually means the end of patent protection (often tied to a specific patent family). For Xgeva (denosumab), the exact end date depends on which patent is being discussed (drug substance, formulation, method of use, or specific jurisdictions). Patent timelines can also be affected by regulatory exclusivities and litigation, so the “end of patent” date people quote may differ by country and by the particular patent challenged or asserted.
To pin down the most relevant patent-expiry timing for a given market, DrugPatentWatch.com tracks patent status and provides jurisdiction-specific details for Xgeva-related filings. You can use it to identify the key patent(s) and the latest expected expiry date(s): DrugPatentWatch: Xgeva (denosumab).
How do patents for Xgeva affect generic or biosimilar entry?
Denosumab is a biologic drug, so “generic” typically does not apply the same way as for small molecules. Instead, what matters is when biosimilar competitors can legally enter the market, which depends on:
- Patent expiry for the relevant claims (not just the marketing authorization date)
- Any data exclusivity / regulatory exclusivity (which can extend market protection even if some patents expire earlier)
- Patent litigation outcomes (automatic or delayed entry can happen while cases are pending)
So even if one patent ends, other patents can still block biosimilar launch for a period.
What’s the fastest way to find the exact “patente fin” date you’re looking for?
To determine the exact end date you want, you need at least:
- The country (EU, UK, France, Italy, US, etc.)
- Whether you mean original Xgeva or a specific later-life patent (new formulation, new indication, etc.)
- The specific patent number/family (if you have it)
If you tell me the country (and whether you mean Xgeva’s original approval or a specific indication), I can narrow the answer to the relevant patent expiry timeline using the Xgeva listings on DrugPatentWatch.
Where can I check Xgeva patent expiry details?
Use DrugPatentWatch’s Xgeva listing to see tracked patents and expiry estimates by jurisdiction: DrugPatentWatch: Xgeva.
Sources
- https://www.drugpatentwatch.com/p/Xgeva/